发明名称 |
SUBSTITUTED PYRIDINONE DERIVATIVES AND METHODS FOR MANUFACTURING THE SAME |
摘要 |
Disclosed are a novel compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and the compound-containing pharmaceutical composition for treating a metabolic disorder. Specifically, the disclosed compound is represented by [Formula 1]. The compound activates GPR119, and thus can be used for treating metabolic disorders, that is, diabetes mellitus, diabetes mellitus-related diseases, diabetes mellitus-related microvessel complications, diabetes mellitus-related large vessel complications, cardiovascular disorders, metabolic syndrome and its constituent diseases, obesity, and other diseases. In Formula 1, P1, P2, P3, P4, L1, R4, n4, X, Y, Z1 and Z2 are the same as defined above. |
申请公布号 |
WO2012011707(A3) |
申请公布日期 |
2012.05.31 |
申请号 |
WO2011KR05268 |
申请日期 |
2011.07.18 |
申请人 |
HYUNDAI PHARM CO., LTD.;PARK, YONG KYU;BANG, SUNG HUN;KIM, JIN WOONG;LEE, HAN KYU;KIM, JAE HYUN;SON, CHANG MO;LEE, JUN HEE;SHIN, CHANG YONG;LEE, JONG CHAN;RHEE, JAE KEOL |
发明人 |
PARK, YONG KYU;BANG, SUNG HUN;KIM, JIN WOONG;LEE, HAN KYU;KIM, JAE HYUN;SON, CHANG MO;LEE, JUN HEE;SHIN, CHANG YONG;LEE, JONG CHAN;RHEE, JAE KEOL |
分类号 |
C07D401/14;A61K31/444;A61P3/00;C07D401/12 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|